Clinical Trials Logo
  1. Home
  2. Gastric Disease
  3. NCT06273319
  4. Details
NCT06273319 Clinical Trial

The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications

Gastric Disease Clinical Trial

Official title:
The Effect of Oxygen Administration With Double Nasal Cannula on Respiratory Complications in Endoscopies

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06273319
Other study ID # 010656
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 15, 2024
Est. completion date June 1, 2024

Study information
Verified date February 2024
Source Inonu University
Contact DUYGU DEMIROZ, dr
Phone +905319504421
Email drduygudemiroz@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare desaturation and respiratory complications by applying oxygen therapy with double nasal cannula to patients who are planned to undergo gastrointestinal endoscopy.

Description:

Two groups of patients scheduled for gastrointestinal endoscopy will be compared in terms of desaturation and respiratory complications by applying 15 litres of oxygen therapy to the first group and 30 litres to the second group with double nasal cannula.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 200
Est. completion date June 1, 2024
Est. primary completion date May 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 18-65 years old PATIENTS WHO WILL HAVE ENDOSCOPY AND OR COLONOSCOPY Exclusion Criteria: - Chronic obstructive pulmonary disease Having low saturation Lung cancer

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• OXYGEN THERAPY
15 AND 30 LT OXYGEN TREATMENT

Locations
Country Name City State
Turkey Inonu universitesi Malatya

Sponsors (1)
Lead Sponsor Collaborator
Inonu University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95% Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95% Up to 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT02105506 - Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses N/A
Completed NCT03198871 - IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population Phase 4
Not yet recruiting NCT06212206 - PillBot™ - Remotely Controlled Capsule Endoscopy N/A
Not yet recruiting NCT03092414 - Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions N/A
Completed NCT03776916 - Application of Simethicone in Esophagogastroscopy N/A
Not yet recruiting NCT02994472 - Gastric Emptying: in Vivo Studies in Healthy Volunteers N/A
Recruiting NCT03267355 - Indications and Outcomes of Endoscopic Ultrasound in Tanta N/A
Completed NCT01322737 - Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System N/A
Completed NCT04111393 - Transoral Removal of Specimen During Laparoscopic Gastric Resection
Recruiting NCT05249933 - Pronase Granules in Gastric Cleaning Phase 2/Phase 3
Completed NCT04479423 - The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy N/A
Completed NCT05392452 - Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB) N/A
Not yet recruiting NCT05801055 - A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone Phase 3